IceCure Medical Ltd. - Ordinary Shares (ICCM)

Icecure Medical Ltd is a pioneering medical technology company that specializes in the development and commercialization of innovative treatments for cancer using its proprietary cryoablation technology

This minimally invasive approach involves the use of extreme cold to target and destroy cancerous cells while preserving surrounding healthy tissue. The company focuses on providing effective solutions for a range of tumors, positioning its products to improve patient outcomes and enhance the overall experience of cancer treatment. Through ongoing research and collaboration with healthcare professionals, Icecure aims to advance the field of oncology and offer patients safer, less invasive alternatives to traditional therapies.